Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.45 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 2/20 | 0.45 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27541113 | 0.98 | POLB (0.51) | POLBCYP2C19MMETBXAS1CNR2 | |
| SCHEMBL4444443 | 0.94 | TBXAS1 (0.51) | POLBCYP2C19MMETBXAS1CNR2 | |
| SCHEMBL1911433 | 0.94 | TBXAS1 (0.51) | POLBCYP2C19MMETBXAS1CNR2 | |
| SCHEMBL2551104 | 0.93 | TBXAS1 (0.54) | POLBCYP2C19TBXAS1CNR2ALDH1A1 | |
| SCHEMBL1290373 | 0.93 | TBXAS1 (0.54) | POLBCYP2C19TBXAS1CNR2ALDH1A1 | |
| SCHEMBL2552649 | 0.93 | TBXAS1 (0.54) | POLBCYP2C19TBXAS1CNR2ALDH1A1 | |
| SCHEMBL2550963 | 0.93 | TBXAS1 (0.54) | POLBCYP2C19TBXAS1CNR2ALDH1A1 | |
| SCHEMBL2554332 | 0.93 | TBXAS1 (0.54) | POLBCYP2C19TBXAS1CNR2ALDH1A1 | |
| SCHEMBL2548840 | 0.93 | TBXAS1 (0.54) | POLBCYP2C19TBXAS1CNR2ALDH1A1 | |
| SCHEMBL1518057 | 0.93 | TBXAS1 (0.54) | POLBCYP2C19TBXAS1CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114573449-B | Catalyst for preparing carboxylic acid chloride by carboxylic acid phosgenation reaction and application thereof | 联化科技（德州）有限公司 | 2024-07-19 | — | — | CN | claimed |
| CN-118026836-A | Preparation method of 4-tert-butylcyclohexyl acetic acid or ester thereof | 中国科学技术大学 | 2024-05-14 | — | — | CN | claimed |
| CN-116121754-B | Organic system Al/Mo etching solution, and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-114790136-A | Preparation method and application of active trivalent organic chromium compound | 中国石油天然气股份有限公司 | 2022-07-26 | — | — | CN | claimed |
| CN-114573449-A | Catalyst for preparing carboxylic acid chloride through carboxylic acid phosgenation reaction and application of catalyst | 联化科技（德州）有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-110256632-B | Preparation method of chromium-free polyolefin resin with high branching degree | 中韩(武汉)石油化工有限公司 | 2022-05-24 | — | — | CN | claimed |
| WO-2019156991-A1 | METHODS OF INHIBITING FORMATION OF ALPHA SYNUCLEIN AGGREGATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-08-15 | — | — | WO | claimed |
| CN-104884065-B | The method for the treatment of cancer | 强烈治疗剂公司 | 2019-01-01 | — | — | CN | claimed |
| CN-108977195-A | A kind of surface ligand is the preparation method of the quantum dot of deprotonation sulfydryl | TCL集团股份有限公司 | 2018-12-11 | — | — | CN | claimed |
| US-20180125803-A1 | METHODS OF INHIBITING PAIN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-05-10 | — | — | US | claimed |
| CN-103119208-A | A biocidal polyolefin yarn with 3-12 filaments | VESTERGAARD FRANDSEN SA | 2013-05-22 | — | — | CN | claimed |
| CN-102832382-A | Method for preparing nano-lithium titanate cathode material | LONG POWER SYSTEMS SUZHOU CO LTD | 2012-12-19 | — | — | CN | claimed |
| CN-102832391-A | Method for preparing LiFe[x]M[1-x]PO4/C lithium ion composite anode material | LONG POWER SYSTEMS SUZHOU CO LTD | 2012-12-19 | — | — | CN | claimed |
| WO-2011124227-A1 | BIOCIDAL ACID-ADJUSTED POLYMER WITH POLYPROPYLENE | VESTERGAARD FRANDSEN SA (CH) | 2011-10-13 | — | — | WO | claimed |
| WO-2011124228-A1 | A BIOCIDAL POLYOLEFIN YARN WITH 3-12 FILAMENTS | VESTERGAARD FRANDSEN SA (CH) | 2011-10-13 | — | — | WO | claimed |
| EP-1716159-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | General Electronic Company (US) | 2006-11-02 | — | — | EP | claimed |
| US-20050256164-A1 | NK1 and NK3 antagonists | PFIZER INC | 2005-11-17 | — | — | US | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2003031609-A1 | ESTERASE ESTA OF RHODOCOCCUS SP. | DEGUSSA AG (DE) | 2003-04-17 | — | — | WO | claimed |
| WO-2003031625-A1 | ESTERASE ESTA EXTRACTED FROM RHODOCOCCUS RUBER | DEGUSSA AG (DE) | 2003-04-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256164-A1 | NK1 and NK3 antagonists | TAC3, TACR1, TACR2 | POLB 4483/4885CYP2C19 2594/4885MME 449/4885 |
| US-20180125803-A1 | METHODS OF INHIBITING PAIN | ATP2A3, ATP2A1, ATP2A2 | POLB 3705/4885CYP2C19 4677/4885MME 376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.